These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas. Ghossein RA; Carusone L; Bhattacharya S In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082 [TBL] [Abstract][Full Text] [Related]
4. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306 [TBL] [Abstract][Full Text] [Related]
5. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group. Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma. Brownbridge GG; Gold J; Edward M; MacKie RM Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559 [TBL] [Abstract][Full Text] [Related]
7. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380 [TBL] [Abstract][Full Text] [Related]
8. Prognosis of metastatic melanoma: no correlation of tyrosinase mRNA in bone marrow and survival time. Waldmann V; Wacker J; Deichmann M; Jäckel A; Bock M; Näher H Recent Results Cancer Res; 2001; 158():118-25. PubMed ID: 11092039 [TBL] [Abstract][Full Text] [Related]
9. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma. Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783 [TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826 [TBL] [Abstract][Full Text] [Related]
12. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. Reinhold U; Lüdtke-Handjery HC; Schnautz S; Kreysel HW; Abken H J Invest Dermatol; 1997 Feb; 108(2):166-9. PubMed ID: 9008229 [TBL] [Abstract][Full Text] [Related]
13. Rapid enrichment and detection of melanoma cells from peripheral blood mononuclear cells by a new assay combining immunomagnetic cell sorting and immunocytochemical staining. Siewert C; Herber M; Hunzelmann N; Fodstad O; Miltenyi S; Assenmacher M; Schmitz J Recent Results Cancer Res; 2001; 158():51-60. PubMed ID: 11092033 [TBL] [Abstract][Full Text] [Related]
14. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma. Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581 [TBL] [Abstract][Full Text] [Related]
15. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779 [TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction in the detection of circulating tumour cells in peripheral blood of melanoma patients. Schittek B; Blaheta HJ; Ellwanger U; Garbe C Recent Results Cancer Res; 2001; 158():93-104. PubMed ID: 11092036 [TBL] [Abstract][Full Text] [Related]
17. Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients. Eide N; Faye RS; Høifødt HK; Øvergaard R; Jebsen P; Kvalheim G; Fodstad Ø Acta Ophthalmol; 2009 Nov; 87(8):830-6. PubMed ID: 19055657 [TBL] [Abstract][Full Text] [Related]
18. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924 [TBL] [Abstract][Full Text] [Related]
19. Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR. Seiter S; Rappl G; Tilgen W; Ugurel S; Reinhold U Recent Results Cancer Res; 2001; 158():105-12. PubMed ID: 11092037 [TBL] [Abstract][Full Text] [Related]
20. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells. Ulmer A; Schmidt-Kittler O; Fischer J; Ellwanger U; Rassner G; Riethmüller G; Fierlbeck G; Klein CA Clin Cancer Res; 2004 Jan; 10(2):531-7. PubMed ID: 14760074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]